Skip to content

Non-Invasive Neurally Adjusted Ventilatory Assist (NAVA) Prone vs Supine in Premature Infants

Effect of Body Position on Oxygenation, Ventilation, and Diaphragmatic Workload in Premature Infants on Non-Invasive Neurally Adjusted Ventilatory Assist (NAVA)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05968586
Enrollment
30
Registered
2023-08-01
Start date
2023-09-11
Completion date
2024-12-31
Last updated
2025-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apnea of Prematurity, Neonatal Oxygen Desaturation, Premature, Ventilator Lung; Newborn

Keywords

apnea of prematurity, NAVA

Brief summary

This research study is being done to investigate the effect of changing an infant's body position on how hard the baby works to breathe, the baby's oxygen level, the baby's carbon dioxide level, the baby's lung volume, the baby's lung compliance (ability of the lung to expand and fill with air), and how frequently the baby develops clinically significant events such as apnea (baby stops breathing on his own), bradycardia (low heart rate), and desaturation (low oxygen) events.

Interventions

Body positioning of infants prone vs supine.

Sponsors

Milton S. Hershey Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Minutes to 3 Months
Healthy volunteers
No

Inclusion criteria

* Viable infants born at ≤32 weeks of gestation on non-invasive NAVA. * Infant must be stable on NAVA for at least 24 hours prior to the study

Exclusion criteria

* Infants with congenital heart disease (CHD) * Infants with persistent pulmonary hypertension (PPHN) * Infants with contraindications to using NAVA (e.g. neuromuscular blockage or paralysis, absent electrical signal from the diaphragm, esophageal tears or bleeding, cardiac pacemakers) or infants in whom an NG/OG catheter cannot be placed.

Design outcomes

Primary

MeasureTime frameDescription
Peak electrical activity of the diaphragm (Edi peaks)From enrollment in study to end of study (a total of twelve hours)Height of Edi signal in uV
Minimum electrical activity of the diaphragm (Edi mins)From enrollment in study to end of study (a total of twelve hours)Lowest of Edi signal in uV
Number of apenic eventsFrom enrollment in study to end of study (a total of twelve hours)Number of times where infant ceases to breath for \>5 seconds
Number of bradycardia eventsFrom enrollment in study to end of study (a total of twelve hours)Number of times where infant's heart rate drops \<100bpm sustained for \>5s
Number of desaturation eventsFrom enrollment in study to end of study (a total of twelve hours)Number of times where infant's oxygen saturation drops \<85% sustained for \>5s

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026